Overview of Acetazolamide
Acetazolamide, with the NDC code 23155-0120, is a medication manufactured by Heritage Pharmaceuticals Inc., doing business as Avet Pharmaceuticals Inc. It is primarily used in the treatment of conditions such as glaucoma, epilepsy, and altitude sickness.
Market Context
Pharmaceutical Market Trends
The pharmaceutical market is experiencing significant changes driven by various factors, including the rise of specialty pharmaceuticals and biotechnology advancements. According to Vizient, Inc., the pharmacy market is projected to see a 3.8% increase in drug prices, largely driven by specialty pharmaceuticals, which include complex and chronic condition treatments[2].
Generic Market Dynamics
Generic drugs like acetazolamide are an integral part of the pharmaceutical market. These drugs often face competition from multiple manufacturers, which can influence pricing. The market for generic drugs is generally more stable in terms of pricing compared to specialty drugs, but it is still subject to fluctuations based on supply and demand, regulatory changes, and the entry of new competitors.
Pricing Factors
Supply and Demand
The pricing of acetazolamide is influenced by supply and demand dynamics. If there is a shortage of the drug or an increase in demand due to its efficacy in treating specific conditions, prices may rise. Conversely, an oversupply or reduced demand can lead to lower prices.
Regulatory Environment
Regulatory changes can significantly impact the pricing of pharmaceuticals. For instance, changes in FDA regulations or the approval of new generic versions can affect the market price of acetazolamide. The evolving regulatory landscape is expected to continue shaping the pharmaceutical industry, including the generic drug market[3].
Competition
The presence of multiple manufacturers for acetazolamide, such as Heritage Pharmaceuticals Inc., contributes to a competitive market. This competition can drive prices down as manufacturers aim to capture market share. However, if one or more manufacturers face production issues or exit the market, prices could increase due to reduced competition.
Price Projections
Current Market
As of the latest available data, the pricing for acetazolamide is relatively stable due to its generic status and the presence of multiple manufacturers. However, specific price data for NDC 23155-0120 is not publicly available in the provided sources.
Future Outlook
Given the overall trends in the pharmaceutical market:
-
Stable Pricing: Generic drugs like acetazolamide tend to have stable pricing due to competition and regulatory oversight. Therefore, significant price increases are unlikely unless there are major disruptions in supply or unexpected increases in demand.
-
Inflationary Pressures: The broader pharmaceutical market is expected to see a 3.8% price increase driven by specialty pharmaceuticals. While this may not directly impact generic drugs, general inflationary pressures could lead to minor price adjustments[2].
-
Regulatory and Market Changes: Any significant regulatory changes or shifts in the competitive landscape could influence pricing. For example, the approval of new generic versions or changes in FDA regulations could impact the market price.
Key Takeaways
- Stable Market: The market for acetazolamide is expected to remain relatively stable due to its generic status and competitive market dynamics.
- Regulatory Influence: Regulatory changes and approvals can impact pricing.
- Supply and Demand: Fluctuations in supply and demand can influence prices.
- Broader Market Trends: While specialty pharmaceuticals drive overall market price increases, generic drugs like acetazolamide are less likely to be significantly affected.
FAQs
What is the primary use of acetazolamide?
Acetazolamide is primarily used in the treatment of conditions such as glaucoma, epilepsy, and altitude sickness.
Who manufactures acetazolamide with NDC 23155-0120?
Heritage Pharmaceuticals Inc., doing business as Avet Pharmaceuticals Inc., manufactures acetazolamide with the NDC code 23155-0120.
What are the key factors influencing the price of acetazolamide?
The price of acetazolamide is influenced by supply and demand dynamics, regulatory changes, and competition from other manufacturers.
Is the price of acetazolamide expected to increase significantly?
No, significant price increases are unlikely for acetazolamide due to its generic status and the competitive market.
How do broader pharmaceutical market trends affect the price of generic drugs like acetazolamide?
While broader market trends, such as the rise of specialty pharmaceuticals, can drive overall price increases, generic drugs like acetazolamide are generally less affected by these trends.
Sources
- FDA Report: NDC 23155-521 Intravenous Injection, Solution Furosemide Drug[1].
- Vizient Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals[2].
- TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025[3].
- GlobalData: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025[4].
- FindACode: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.[5].
Last updated: 2025-01-01
